Use

Oncology FISH Analysis - STAT MDS is a Fluorescence In Situ Hybridization (FISH) test tailored to identify chromosomal abnormalities linked with myelodysplastic syndrome (MDS). MDS comprises a constellation of myeloid disorders that can lead to bone marrow dysfunction and dysplasia. This analysis is crucial, as specific abnormalities detected can inform both diagnosis and prognosis. For instance, certain abnormalities might suggest a favorable prognosis when identified in isolation, while others could indicate treatment resistance or progression to acute myeloid leukemia (AML). Consequently, the results must always be integrated with clinical and pathological context to guide treatment decisions effectively.